LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Ruxolitinib | 10 | uM | LJP5 | 2 | O13 | 72 | hr | 658 | 2769 | 3953 | 0.7004 | 0.7427 |
Hs 578T | Ruxolitinib | 10 | uM | LJP5 | 3 | O13 | 72 | hr | 658 | 2665 | 3938 | 0.6767 | 0.7191 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 1 | P12 | 72 | hr | 658 | 3658 | 3908 | 0.9359 | 0.9491 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 2 | P12 | 72 | hr | 658 | 3622 | 3953 | 0.9161 | 0.9334 |
Hs 578T | Momelotinib | 0.04 | uM | LJP5 | 3 | P12 | 72 | hr | 658 | 3793 | 3938 | 0.9631 | 0.9711 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 1 | P11 | 72 | hr | 658 | 3157 | 3908 | 0.8077 | 0.8406 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 2 | P11 | 72 | hr | 658 | 3234 | 3953 | 0.8180 | 0.8505 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 3 | P11 | 72 | hr | 658 | 3290 | 3938 | 0.8354 | 0.8654 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 1 | P10 | 72 | hr | 658 | 2673 | 3908 | 0.6839 | 0.7251 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 2 | P10 | 72 | hr | 658 | 2821 | 3953 | 0.7135 | 0.7553 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 3 | P10 | 72 | hr | 658 | 2928 | 3938 | 0.7434 | 0.7830 |
Hs 578T | Momelotinib | 1.11 | uM | LJP5 | 1 | P09 | 72 | hr | 658 | 2185 | 3908 | 0.5590 | 0.5950 |
Hs 578T | Momelotinib | 1.11 | uM | LJP5 | 2 | P09 | 72 | hr | 658 | 2111 | 3953 | 0.5339 | 0.5692 |
Hs 578T | Momelotinib | 1.11 | uM | LJP5 | 3 | P09 | 72 | hr | 658 | 2226 | 3938 | 0.5652 | 0.6033 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 1 | P08 | 72 | hr | 658 | 1291 | 3908 | 0.3303 | 0.2997 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 2 | P08 | 72 | hr | 658 | 1281 | 3953 | 0.3240 | 0.2936 |
Hs 578T | Momelotinib | 3.33 | uM | LJP5 | 3 | P08 | 72 | hr | 658 | 1358 | 3938 | 0.3448 | 0.3239 |
Hs 578T | Momelotinib | 10 | uM | LJP5 | 1 | P07 | 72 | hr | 658 | 557 | 3908 | 0.1425 | -0.0629 |
Hs 578T | Momelotinib | 10 | uM | LJP5 | 2 | P07 | 72 | hr | 658 | 498 | 3953 | 0.1260 | -0.1022 |
Hs 578T | Momelotinib | 10 | uM | LJP5 | 3 | P07 | 72 | hr | 658 | 628 | 3938 | 0.1595 | -0.0180 |
Hs 578T | Fedratinib | 0.04 | uM | LJP5 | 1 | L06 | 72 | hr | 658 | 3844 | 3908 | 0.9835 | 0.9871 |
Hs 578T | Fedratinib | 0.04 | uM | LJP5 | 2 | L06 | 72 | hr | 658 | 3932 | 3953 | 0.9945 | 0.9958 |
Hs 578T | Fedratinib | 0.04 | uM | LJP5 | 3 | L06 | 72 | hr | 658 | 3885 | 3938 | 0.9864 | 0.9894 |
Hs 578T | Fedratinib | 0.12 | uM | LJP5 | 1 | L05 | 72 | hr | 658 | 3670 | 3908 | 0.9390 | 0.9516 |
Hs 578T | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 658 | 3974 | 3953 | 1.0051 | 1.0040 |